Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
International Journal of Cancer|March 28, 1996
Effect of ionizing radiation on cell-cycle progression and cyclin B1 expression in human melanoma cellsR Villa, N Zaffaroni, A Bearzatto, et al.Current Medicinal Chemistry|June 12, 2012
Namitecan: a hydrophilic camptothecin with a promising preclinical profileG L Beretta, V Zuco, M De Cesare, et al.Cellular and Molecular Life Sciences : CMLS|July 9, 2004
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cellsC Brambilla, M Folini, P Gandellini, et al.International Journal of Radiation Biology|September 1, 1994
DNA double-strand break repair and radiation response in human tumour primary culturesN Zaffaroni, L Orlandi, R Villa, et al.Anticancer Research|January 1, 1990
Absolute and relative activities of 4' -iodo-4'-deoxydoxorubicin against human colo-rectal tumors, as evaluated by a short-term in vitro assayR Villa, N Zaffaroni, F C Giuliani, et al.European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Fludarabine as a modulator of cisplatin activity in human tumour primary cultures and established cell linesN Zaffaroni, L Orlandi, D Gornati, et al.International Journal of Cancer|October 10, 1998
Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosisL Orlandi, N Zaffaroni, A Bearzatto, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancersS Veneroni, N Zaffaroni, M G Daidone, et al.International Journal of Cell Cloning|November 1, 1989
Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanomaN Zaffaroni, R Villa, M G Daidone, et al.International Journal of Cancer|October 21, 1993
Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cellsR Silvestrini, N Zaffaroni, A Costa, et al.Pageof 9